NCT00770978View on ClinicalTrials.gov

Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
ICU
Interventions
DRUG

ceftobiprole q12h

Ceftobiprole, 1G q12h as 4 hour infusions, on Day 1 and Ceftobiprole, 1G as single 4 hour infusion on Day 2

DRUG

ceftobiprole q8h

Ceftobiprole, 1G q8h as 4 hour infusions, on Day 1 and Ceftobiprole, 1G as single 4 hour infusion on Day 2

Trial Locations (13)

Unknown

Birmingham

Chicago

Beech Grove

Omaha

Aalst

Edegem

Greenfield Park

Jerusalem

Gwangju

Incheon

Seoul

Barcelona

Madrid

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY

NCT00770978 - Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU | Biotech Hunter | Biotech Hunter